Utilidad del estudio PET con FDG en la evaluación de sarcomas de diverso origen y de tumores no sarcoma-no epiteliales / Positron emission tomography with fluorine-deoxyglucose in sarcomas and non-sarcoma non-epithelial tumors
Rev. méd. Chile
;
140(9): 1116-1125, set. 2012. ilus
Artículo
en Español
| LILACS
| ID: lil-660068
ABSTRACT
Background:
The usefulness of positron emission tomography (PET) with fluorine-deoxyglucose (FDG) in sarcomas and non-sarcoma non-epithelial (NSNE) tumors is not clearly defined.Aim:
To report a Chilean experience with NSNE tumors evaluated using PET with FDG. Material andMethods:
Retrospective review of the database of a PET laboratory. Demographic data, indications and metabolic findings were compared with conventional imaging in 88 adults and children with diverse bone and soft tissue sarcomas as well as 24 gastrointestinal stromal tumors (GIST), 6 pleural malignant mesotheliomas in adults, and 9 medulloblastomas in children.Results:
FDG showed good concordance with conventional imaging in NSNE tumors. It was helpful for staging, restaging, follow-up after treatment and for the detection of new not previously suspected lesions.Conclusions:
PET with FDG could have a prognostic role and help in patient management, mainly in musculos-keletal and high grade or less differentiated sarcomas. In GIST, it was a good tool for immunotherapy control.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Sarcoma
/
Radiofármacos
/
Tomografía de Emisión de Positrones
/
Neoplasias
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
Límite:
Adolescente
/
Adulto
/
Anciano
/
Aged80
/
Niño
/
Child, preschool
/
Femenino
/
Humanos
/
Masculino
Idioma:
Español
Revista:
Rev. méd. Chile
Asunto de la revista:
Medicina
Año:
2012
Tipo del documento:
Artículo
País de afiliación:
Chile
Institución/País de afiliación:
Hospital Clínico Universidad de Chile/CL
Similares
MEDLINE
...
LILACS
LIS